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Food supplements, including herbal and dietary,
constitute one of the fastest growing industries with
expenditures reaching worldwide $60 billion annually.
Sales of herbal dietary supplements in the United
States increased by 7.9% in 2013, reaching a total
estimated figure of six billion dollars (Lindstrom et al.,
2014). These sales account for approximately 20% of
the overall drug market (Kirk and Dunker, 2014). The
use of herbal supplements increased 20 times in the
last 25 years, counting in 2013 with ~ 50% of the USA
adult population as consumers (Bailey et al., 2013).
Yet, while the appetite of consumers for supplements
continues to increase, regulatory safety guidelines and
the knowledge of their effects are lacking.
Perhaps change is in the air. An uproar was
raised after the investigation results of the New York
State Attorney General’s office were reported in New
York Times February 3, 2015 (Assoc. Press, 2015).
Accusations that herbal supplements do not contain the
listed ingredients prompted major retailers, including
Walgreens, Wal-Mart, GNC, and Target, to stop
selling several herbal supplements, including some
store brands of ginseng (Panax trifolius), gingko
(Gingko biloba), echinacea (Echinacea spp.) and St.
John's wort (Hypericum perforatum). These herbal
supplements contained some plant compon-ents,
including carrot powder, but no principal active
compounds responsible for the alleged beneficial
effects were detected.
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Our team has been investigating the molecular
mechanisms of plant flavonoids in health using several
model systems during the past few years. Apigenin, a
flavonoid abundant in celery and parsley, two
vegetables that are quite common in the Mediterranean
diet, is emerging as a promising anti-cancer and
immune-regulatory molecule (Shukla and Gupta.,
2010). Our studies have shown that apigenin and diets
rich in apigenin induce apoptosis in cancer cells, alter
cancer proliferative gene expression, re-duce
inflammation and restore normal metabolic function
(Nahomi et al., 2013). Yet, the effects of supplements
containing apigenin have not been studied.
As part of our efforts to investigate the
mechanisms responsible for the beneficial health
effects of dietary compounds, the content of apigenin
was studied in several herbal supplements, using
commonly accepted analytical assessments (Figure 1).
In agreement with the observations of the New York
State Attorney General’s Office, we noted several
label discrepancies in the reported amounts and
contents, highlighting the inconsistencies between label
claims and supplement contents.
In the past few years, several incidents in
which label discrepancies have been reported, highlighting the need for greater government oversight.
Dietary supplements in USA are regulated by The U.S.
Food and Drug Administration (FDA), but under a
different set of guidelines than those covering

Parihar et al.: The Saga of Food Supplements: Safety and Missing Knowledge – A C

“classical” foods and drugs. Based on the Dietary
Supplement Health and Education Act of 1994,
supplement makers, unlike manufacturers for conventional drugs, are exempt from demonstrating that their
products are safe or effective. The only require-ment
is to report accurate and truthful labels. If the FDA
becomes aware of an unsafe supplement being
marketed, they may request a warning be included on
the label or the product be removed from the market.
The regulations for dietary supplements should
be framed to ensure that consumers are protected and
that the product is effective. The need for revised
guidelines is becoming even more relevant considering
that 45-50% of the USA adult population, ~16.4% of
adolescents, and ~7 to 10.7% of children ages 5-11
consume herbal supplements (Bailey et al., 2013).
Racial, cultural and socio-economical differences in
consumption have been reported. Approximately 50%
of Native Americans and 43% of whites use
supplements and increased use has been associated
with higher income (Barnes et al., 2008). Supplements
classified as non-mineral and non-vitamin are used by
18% of adults (Barnes et al., 2008). Fish oil (omega
3) has been reported as the most common supplement
consumed in the United States (Barnes et al., 2004;
Barnes, 2008),, yet the efficacy of this supplement
remains unknown.
Considered alternative medicines, herbal supplements are thus commonly combined with other
prescription medicines. Of supplement consumers,
72% also use prescription medications and 84% have
consumed an over-the counter medication in the prior
12 months (Gardiner et al., 2007). Remarkably, a
report published in 2007, indicates that most medical
doctors were unaware that dietary supplements are
subject to different FDA regulations than foods or
prescription medicines (Ashar, et al., 2007). Clinically
serious interactions between prescription drugs and
supplements have been noted in several reports
(Kaufman et al., 2002; Ernst, 2000; Mills et al., 2004;
Sorensen, 2002; Valli and Giardina, 2002). Yet, any
clinical studies that evaluate the effects of supplements in combination with other drugs are, missing.

Surveys indicate that approximately 19% of the
USA population have used herbs for health conditions,
such as head or chest cold, a musculoskeletal condition, stomach or intestinal illness, anxiety/depression,
insomnia, severe headache or migraine, menopause,
cholesterol, and recurring pain (Barnes, et al., 2004;
Gardiner et al., 2007; Tindle et al., 2005; Ni et al.,
2002; Fennell, 2004; Graham et al., 2005). The
consumer needs a better understanding and evidence
on the benefits, and risks, associated with supplements.
The lack of quality control of herbal
compounds at the manufacturer level is a serious
concern in that the therapeutic effects of the compounds are frequently overstated. While central
control features related to security and composition
can be obtained through useful and accepted analytical
approaches, little has been done. Regret-tably, such
controls are still greatly needed.
In recent years, the availability of publications
of scientific data has been rapidly increasing, but
dietary studies using supplements alone or in
combination are scarce. To bring the true effects of
supplements to clinical and public view, an increased
sponsorship of clinical studies is very much needed.
Moreover, supplemental nutrition and herbal medicine should be prescribed by certified professionals
rather than by a free and misinformed market. Urgent
changes are needed to: 1) to update the regulations on
supplements and establish clear safety guidelines for
consumers; 2) to gain a better understanding of the
mechanisms of supplement actions and effects; and 3)
to determine and evaluate the possible interactions of
supplements with drugs.
As consumer demand for supplements
continues to increase, limited funding for research and
outdated safety guidelines are alarming. More and
better information on supplements is needed. Yet, any
analytical studies on supplements will apparently
continue to be delayed due to a government, paralyzed
by lobbyists and lack funding, continues to avoid the
real question: as to whether supplements are really
safe and effective?
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Figure 1. Content of apigenin in different supplements.
Fig. 1A is apigenin standard obtained from Sigma-Aldrich, Inc.
Fig. 1B is content of apignin per capsule was 9.73 mg
whereas label indicates 50 mg/capsule.

Fig. 1C & Fig 1D are chromatograms of two other
supplements from different manufacturers,
but expected flavonoids were not detected.

Note: For analysis, ten supplement capsules were extracted three times with 70% methanol, filtered through a 0.2 μM
membrane, and 20 μL of each sample was injected into a Waters 2695 separation module with a 2996 detector
W2690-5 Symmetry C18 column (3.5 μm , 4.6 x 75 mm) and subsequently analyzed using Empower software
(Waters Corp., Milford, MA). Concentrations were measured at 340 nm corresponding to the absorbance
wavelength for apigenin.
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